Company search
Biotechnology & Healthcare: a sector on the mend?
What’s the prognosis for biotech and healthcare companies? How will the US election impact the sector, and could we see a recovery later this year?
Overview
Performance
Portfolio
Dividends
Charges
Gearing
Research
Announcements
Management
Documents
Invest
Engage
Research
Edison
22 January 2024
Edison’s head of investment companies, Rob Murphy, met Roderick Wong, managing director of RTW Investments.
Related articles
Could AI “serve as a catalyst driving the biotech industry into the future”?
Biotechnology & Healthcare investment companies comment on the “bright” outlook for the sector.
Related Industry News
RTW Biotech sells Arix holdings to position for flotation recovery
Fund manager Rod Wong sells Arix Bioscience's listed holdings following its acquisition by RTW and puts the $128m raised into the portfolio at an ‘ideal time’ as initial public offers revive.
Numis: Six trust tips for a bet on re-rated growth
Better late than never, Deutsche Numis analysts review their annual investment company recommendations, adding six listed funds and removing three.
Numis: Six trust tips for a bet on rerated growth
Better late than never, Deutsche Numis analysts review their annual investment company recommendations, adding six listed funds and removing three.
David Stevenson: Biotech has turned from the bear
After a tough few years, increased fundraising suggests sentiment has improved and the current rally in biotech and life sciences could persist.
Investment company news brought to you by Citywire Financial Publishers Limited
and QuotedData by Marten & Co.
Data provided by Morningstar.
Company documents provided by FE fundinfo.
